RxNorm 1000112

Medroxyprogesterone acetate

RxNorm Semantic Concepts

RxNorm semantic concepts for the RxCUI 1000112 unique identifier include: medroxyprogesterone acetate (3281929), medroxyPROGESTERone acetate (3733572), Medroxyprogesterone acetate (436106) and Medroxyprogesterone acetate (substance) (436124).

RxNorm Atom ID: 3281929 - Precise Ingredient
medroxyprogesterone acetate

RXCUI:
1000112 - RxNorm Unique Identifier for a concept (Concept ID)
LAT:
ENG - Language of the Term
RXAUI:
3281929 - Unique identifier for the atom (RxNorm Atom ID)
Is Prescribable?
YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Concept Description:
medroxyprogesterone acetate - Description of concept identifier
Term Type (TTY):
PIN - Term type in source with name and description
Term Type Name:
Precise Ingredient - Name of term type in source
Term Type Description:
A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. - Description of term type in source
Code:
1000112 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Suppress Flag:
N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF:
4096 - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
RxNorm to UNII Crosswalk:
C2QI4IOI2G - MEDROXYPROGESTERONE ACETATE ([C@]12(C(=CC(CC1)=O)[C@@H](C)C[C@@]3([C@@]2(CC[C@@]4([C@@](OC(=O)C)(C(=O)C)CC[C@@]34[H])C)[H])[H])C) - RxNorm to UNII (Unique Ingredient Identifier) Crosswalk
Source:
RXNORM - Concept source abbreviation
Source Name:
RxNorm Vocabulary - The official name for a source
Source Version:
20AA_240304F - The source version
Source Date:
March 04, 2024 - RxNorm data last updated
Source License Contact:
RxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source license contact information
Source Content Contact:
RxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source content contact information
Source Short Name:
RxNorm work done by the National Library of Medicine - The short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom ID: 3733572 - Tall Man Lettering Synonym
medroxyPROGESTERone acetate

RXCUI:
1000112 - RxNorm Unique Identifier for a concept (Concept ID)
LAT:
ENG - Language of the Term
RXAUI:
3733572 - Unique identifier for the atom (RxNorm Atom ID)
Is Prescribable?
YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Concept Description:
medroxyPROGESTERone acetate - Description of concept identifier
Term Type (TTY):
TMSY - Term type in source with name and description
Term Type Name:
Tall Man Lettering Synonym - Name of term type in source
Term Type Description:
Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. - Description of term type in source
Code:
1000112 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Suppress Flag:
N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF:
4096 - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
RxNorm to UNII Crosswalk:
C2QI4IOI2G - MEDROXYPROGESTERONE ACETATE ([C@]12(C(=CC(CC1)=O)[C@@H](C)C[C@@]3([C@@]2(CC[C@@]4([C@@](OC(=O)C)(C(=O)C)CC[C@@]34[H])C)[H])[H])C) - RxNorm to UNII (Unique Ingredient Identifier) Crosswalk
Source:
RXNORM - Concept source abbreviation
Source Name:
RxNorm Vocabulary - The official name for a source
Source Version:
20AA_240304F - The source version
Source Date:
March 04, 2024 - RxNorm data last updated
Source License Contact:
RxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source license contact information
Source Content Contact:
RxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source content contact information
Source Short Name:
RxNorm work done by the National Library of Medicine - The short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom ID: 436106 - Designated preferred name
Medroxyprogesterone acetate

RXCUI:
1000112 - RxNorm Unique Identifier for a concept (Concept ID)
LAT:
ENG - Language of the Term
RXAUI:
436106 - Unique identifier for the atom (RxNorm Atom ID)
Is Prescribable?
YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Concept Description:
Medroxyprogesterone acetate - Description of concept identifier
Term Type (TTY):
PT - Term type in source with name and description
Term Type Name:
Designated preferred name - Name of term type in source
Term Type Description:
- Description of term type in source
Code:
126112002 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Suppress Flag:
N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF:
- Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
RxNorm to UNII Crosswalk:
C2QI4IOI2G - MEDROXYPROGESTERONE ACETATE ([C@]12(C(=CC(CC1)=O)[C@@H](C)C[C@@]3([C@@]2(CC[C@@]4([C@@](OC(=O)C)(C(=O)C)CC[C@@]34[H])C)[H])[H])C) - RxNorm to UNII (Unique Ingredient Identifier) Crosswalk
Source:
SNOMEDCT_US - Concept source abbreviation
Source Name:
US Edition of SNOMED CT - The official name for a source
Source Version:
2024_01_01 - The source version
Source Date:
March 04, 2024 - RxNorm data last updated
Source License Contact:
National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)

https://support.nlm.nih.gov/support/create-case/
- The source license contact information
Source Content Contact:
National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library Of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)

https://support.nlm.nih.gov/support/create-case/
- The source content contact information
Source Short Name:
US Edition of SNOMED CT - The short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom ID: 436124 - Full form of descriptor
Medroxyprogesterone acetate (substance)

RXCUI:
1000112 - RxNorm Unique Identifier for a concept (Concept ID)
LAT:
ENG - Language of the Term
RXAUI:
436124 - Unique identifier for the atom (RxNorm Atom ID)
Is Prescribable?
YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Concept Description:
Medroxyprogesterone acetate (substance) - Description of concept identifier
Term Type (TTY):
FN - Term type in source with name and description
Term Type Name:
Full form of descriptor - Name of term type in source
Term Type Description:
- Description of term type in source
Code:
126112002 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Suppress Flag:
N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF:
- Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
RxNorm to UNII Crosswalk:
C2QI4IOI2G - MEDROXYPROGESTERONE ACETATE ([C@]12(C(=CC(CC1)=O)[C@@H](C)C[C@@]3([C@@]2(CC[C@@]4([C@@](OC(=O)C)(C(=O)C)CC[C@@]34[H])C)[H])[H])C) - RxNorm to UNII (Unique Ingredient Identifier) Crosswalk
Source:
SNOMEDCT_US - Concept source abbreviation
Source Name:
US Edition of SNOMED CT - The official name for a source
Source Version:
2024_01_01 - The source version
Source Date:
March 04, 2024 - RxNorm data last updated
Source License Contact:
National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)

https://support.nlm.nih.gov/support/create-case/
- The source license contact information
Source Content Contact:
National Library Of Medicine
NLM is a Charter Member of SNOMED International on behalf of the U.S.
National Library Of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
1-888-FIND-NLM (1-888-346-3656)

https://support.nlm.nih.gov/support/create-case/
- The source content contact information
Source Short Name:
US Edition of SNOMED CT - The short name of a source as used by the NLM Knowledge Source Server

* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Patient Education

Estrogen and Progestin (Hormone Replacement Therapy)


Combinations of estrogen and progestin are used to treat certain symptoms of menopause. Estrogen and progestin are two female sex hormones. Hormone replacement therapy works by replacing estrogen hormone that is no longer being made by the body. Estrogen reduces feelings of warmth in the upper body and periods of sweating and heat (hot flashes), vaginal symptoms (itching, burning, and dryness) and difficulty with urination, but it does not relieve other symptoms of menopause such as nervousness or depression. Estrogen also prevents thinning of the bones (osteoporosis) in menopausal women. Progestin is added to estrogen in hormone replacement therapy to reduce the risk of uterine cancer in women who still have their uterus.
[Learn More]


Medroxyprogesterone


Medroxyprogesterone is used to treat abnormal menstruation (periods) or irregular vaginal bleeding. Medroxyprogesterone is also used to bring on a normal menstrual cycle in women who menstruated normally in the past but have not menstruated for at least 6 months and who are not pregnant or undergoing menopause (change of life). Medroxyprogesterone is also used to prevent overgrowth of the lining of the uterus (womb) and may decrease the risk of cancer of the uterus in patients who are taking estrogen. Medroxyprogesterone is in a class of medications called progestins. It works by stopping the growth of the lining of the uterus and by causing the uterus to produce certain hormones.
[Learn More]


Medroxyprogesterone Injection


Medroxyprogesterone intramuscular (into a muscle) injection and medroxyprogesterone subcutaneous (under the skin) injection are used to prevent pregnancy. Medroxyprogesterone subcutaneous injection is also used to treat endometriosis (a condition in which the type of tissue that lines the uterus (womb) grows in other areas of the body and causes pain, heavy or irregular menstruation [periods], and other symptoms). Medroxyprogesterone is in a class of medications called progestins. It works to prevent pregnancy by preventing ovulation (the release of eggs from the ovaries). Medroxyprogesterone also thins the lining of the uterus. This helps to prevent pregnancy in all women and slows the spread of tissue from the uterus to other parts of the body in women who have endometriosis. Medroxyprogesterone injection is a very effective method of birth control but does not prevent the spread of human immunodeficiency virus (HIV, the virus that causes acquired immunodeficiency syndrome [AIDS]) or other sexually transmitted diseases.
[Learn More]


* Please review the disclaimer below.